Global Drug Screening Market Overview And Scope:
Global Drug Screening Market Size was estimated at USD 4448.25 million in 2022 and is projected to reach USD 6188.06 million by 2028, exhibiting a CAGR of 5.66% during the forecast period.
The Global Drug Screening Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Drug Screening utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific
Global Drug Screening Market Segmentation
By Type, Drug Screening market has been segmented into:Immunoassay Analyzers
Chromatography
Breath Analyzers
Rapid Testing Devices
Assay Kits and Reagents
By Application, Drug Screening market has been segmented into:
Hospitals
Research Institute
Biotechnology and Pharmaceutical Companies
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Screening market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Screening market.
Top Key Players Covered in Drug Screening market are:
Abbott
Express Diagnostics
Laboratory Corporation of America
MPD
Quest Diagnostics
Roche Diagnostics
Shimadzu
Siemens Healthcare
Thermo Fisher Scientific
Objective to buy this Report:
1. Drug Screening analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Drug Screening market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Drug Screening Market by Type
5.1 Drug Screening Market Overview Snapshot and Growth Engine
5.2 Drug Screening Market Overview
5.3 Immunoassay Analyzers
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay Analyzers: Geographic Segmentation
5.4 Chromatography
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Chromatography: Geographic Segmentation
5.5 Breath Analyzers
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Breath Analyzers: Geographic Segmentation
5.6 Rapid Testing Devices
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Rapid Testing Devices: Geographic Segmentation
5.7 Assay Kits and Reagents
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Assay Kits and Reagents: Geographic Segmentation
Chapter 6: Drug Screening Market by Application
6.1 Drug Screening Market Overview Snapshot and Growth Engine
6.2 Drug Screening Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Research Institute
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Research Institute: Geographic Segmentation
6.5 Biotechnology and Pharmaceutical Companies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Biotechnology and Pharmaceutical Companies: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Drug Screening Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Drug Screening Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Drug Screening Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 EXPRESS DIAGNOSTICS
7.4 LABORATORY CORPORATION OF AMERICA
7.5 MPD
7.6 QUEST DIAGNOSTICS
7.7 ROCHE DIAGNOSTICS
7.8 SHIMADZU
7.9 SIEMENS HEALTHCARE
7.10 THERMO FISHER SCIENTIFIC
Chapter 8: Global Drug Screening Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Immunoassay Analyzers
8.2.2 Chromatography
8.2.3 Breath Analyzers
8.2.4 Rapid Testing Devices
8.2.5 Assay Kits and Reagents
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Research Institute
8.3.3 Biotechnology and Pharmaceutical Companies
8.3.4 Others
Chapter 9: North America Drug Screening Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Immunoassay Analyzers
9.4.2 Chromatography
9.4.3 Breath Analyzers
9.4.4 Rapid Testing Devices
9.4.5 Assay Kits and Reagents
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Research Institute
9.5.3 Biotechnology and Pharmaceutical Companies
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Drug Screening Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Immunoassay Analyzers
10.4.2 Chromatography
10.4.3 Breath Analyzers
10.4.4 Rapid Testing Devices
10.4.5 Assay Kits and Reagents
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Research Institute
10.5.3 Biotechnology and Pharmaceutical Companies
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Drug Screening Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Immunoassay Analyzers
11.4.2 Chromatography
11.4.3 Breath Analyzers
11.4.4 Rapid Testing Devices
11.4.5 Assay Kits and Reagents
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Research Institute
11.5.3 Biotechnology and Pharmaceutical Companies
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Drug Screening Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Immunoassay Analyzers
12.4.2 Chromatography
12.4.3 Breath Analyzers
12.4.4 Rapid Testing Devices
12.4.5 Assay Kits and Reagents
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Research Institute
12.5.3 Biotechnology and Pharmaceutical Companies
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Drug Screening Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Immunoassay Analyzers
13.4.2 Chromatography
13.4.3 Breath Analyzers
13.4.4 Rapid Testing Devices
13.4.5 Assay Kits and Reagents
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Research Institute
13.5.3 Biotechnology and Pharmaceutical Companies
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Drug Screening Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Immunoassay Analyzers
14.4.2 Chromatography
14.4.3 Breath Analyzers
14.4.4 Rapid Testing Devices
14.4.5 Assay Kits and Reagents
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Research Institute
14.5.3 Biotechnology and Pharmaceutical Companies
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Drug Screening Scope:
|
Report Data
|
Drug Screening Market
|
|
Drug Screening Market Size in 2025
|
USD XX million
|
|
Drug Screening CAGR 2025 - 2032
|
XX%
|
|
Drug Screening Base Year
|
2024
|
|
Drug Screening Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific.
|
|
Key Segments
|
By Type
Immunoassay Analyzers
Chromatography
Breath Analyzers
Rapid Testing Devices
Assay Kits and Reagents
By Applications
Hospitals
Research Institute
Biotechnology and Pharmaceutical Companies
Others
|
